Severe rosacea in a patient on infliximab for ulcerative colitis: Pathophysiological considerations

Acta Dermato-Venereologica

Volumn 89, Issue 5, 2009, Pages 522-523

  Kosmidou, Maria ^a   Gaitanis, Georgios ^a   Nomikos, Katon ^a   Zioga, Aikaterini ^a   Katsanos, Konstantinos ^a   Bassukas, Ioannis D ^a   Tsianos, Epameinondas ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DOXYCYCLINE; INFLIXIMAB; MESALAZINE; PREDNISONE; PROPRANOLOL;

ADULT; CASE REPORT; CLINICAL EXAMINATION; DISEASE SEVERITY; DRUG TOLERABILITY; HUMAN; HUMAN TISSUE; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; ROSACEA; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIOPSY; COLITIS, ULCERATIVE; DERMATOLOGIC AGENTS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; ROSACEA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350175875     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0681     Document Type: Letter

References (15)

1. Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 2008; 135: 1442-1447.
2. Passarini B, Infusimo SD, Barbieri E, Varotti E, Gionchetti P, Rizzello F, et al. Cutaneous manifestation in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy. Dermatology 2007; 215: 295-300. (Pubitemid 47519257)
3. Crawford G, Pelle MT, James W. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-341.
4. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2004; 50: 907-912. (Pubitemid 38685771)
5. Jansen T, Romiti R, Kreuter A, Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol 2001; 15: 484-485. (Pubitemid 33040130)
6. Winter UM, Treudler R, Paasch U, Sticherling M, Simon JC. Ein Fall von granulomatöser Rosazea im zeitlichen Zusammenhang mit Etanercept. Hautarzt 2008; 59: 724-727.
7. Becker M, Rosé CD, McIlvain-Simpson G. Niacin-like reaction to infliximab in systemic juvenile rheumatoid arthritis. J Rheumatol 2004; 31: 2529-2530. (Pubitemid 39603112)
8. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005; 366: 843-855. (Pubitemid 41557385)
9. Van Steensel MA, Badeloe S, Winnepenninckx V, Vreeburg M, Steijlen PM, Van Geel M. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn- associated NOD2/CARD15 polymorphism R702W. Exp Dermatol 2008; 17: 1057-1058.
10. Arimone Y, Bégaud B, Miremont-Salamé G, Fourrier-Réglat A, Molimard M, Moore N, Haramburu F. A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol 2006; 59: 308-314. (Pubitemid 43243657)
11. Yamasaki K, Di Nardo A, Bardan A, MurakamiM, Ohtake T, Coda A, et al. Increase serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-980. (Pubitemid 47222043)
12. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007; 157: 474-481. (Pubitemid 47256121)
13. Yagdiran Düzgün O, Aytekin S. Comparison of Demodex folliculorum density in haemodialysis patients with a control group. J Eur Acad Dermatol Venereol 2007; 21: 480-483. (Pubitemid 46454900)
14. Mookherjee N, Wilson HL, Doria S, Popowych Y, Falsafi R, Yu JJ, et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharides. J Leukocyt Biol 2006; 80: 1563-1574. (Pubitemid 44904995)
15. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock REW. Impact of LL-37 on anti-infective immunity. J Leukocyt Biol 2005; 77: 451-459.